Russia's Gamaleya institute is launching pre-clinical trials of an intranasal vaccine against the coronavirus, institute director Alexander Gintsburg said in an interview with Sputnik
MOSCOW (Pakistan Point News / Sputnik - 02nd April, 2021) Russia's Gamaleya institute is launching pre-clinical trials of an intranasal vaccine against the coronavirus, institute director Alexander Gintsburg said in an interview with Sputnik.
It was revealed in mid-February that Russian scientists had developed a nose spray form of the Sputnik V vaccine. Moscow Mayor Sergei Sobyanin said back then that the two-component drug would not replace full vaccination but could be used as additional protection.
"We have obtained a patent for the intranasal vaccine. In fact, we are now launching pre-clinical trials," Gintsburg revealed.
